Acute Sore Throat Pain Study

• Status: Completed
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: All

Summary

"Sore throat is one of the most common complaints encountered in clinical practice. And in 65% of cases, the infection is thought to be viral in nature.

The aim of this study is to evaluate the analgesic profile of 3 Ibuprofen lozenges after single administration in acute sore throat pain."

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pierre Fabre Medicament
• Treatments: Flurbiprofen; Ibuprofen

Criteria

Inclusion Criteria:

• male or female patients 18 years and older

• patients with a sore throat associated or not with an Upper Respiratory Tract Infection ≥ 24 hours and ≤ 5 days duration, in the absence of Streptococcus group A

Exclusion Criteria:

• patients with hypersensitivity to Ibuprofen or other NSAIDs or the excipients.

• patients having used analgesics or antiseptics or any topical throat treatment or any local medication containing a local oral anaesthetic within 6 hours before study entry and who use analgesics more than ≥ 3 times per week.

• patients having used any anti inflammatory treatment or any long-acting or slow release analgesics within 12 hours before study entry

• patients having taken antibiotics within 14 days before study entry.